We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

89 hedge funds and large institutions have $249M invested in Aldeyra Therapeutics in 2018 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 8

247% more call options, than puts

Call options by funds: $1.98M | Put options by funds: $571K

158% more capital invested

Capital invested by funds: $96.4M → $249M (+$152M)

138% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 13

35% more funds holding

Funds holding: 66 → 89 (+23)

25.21% more ownership

Funds ownership: 60.33% → 85.54% (+25%)

Holders
89
Holders Change
+23
Holders Change %
+34.85%
% of All Funds
2.03%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.09%
New
31
Increased
31
Reduced
13
Closed
8
Calls
$1.98M
Puts
$571K
Net Calls
+$1.41M
Net Calls Change
+$1.37M

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$8.27M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.73M
3
KCM
Knoll Capital Management
Florida
+$2.92M
4
6CM
683 Capital Management
New York
+$2.84M
5
EI
EAM Investors
California
+$2.53M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.91M
2
SLG
Stanley-Laman Group
Pennsylvania
-$786K
3
JP Morgan Chase
JP Morgan Chase
New York
-$455K
4
EIM
Essex Investment Management
Massachusetts
-$312K
5
PCM
Prelude Capital Management
New York
-$141K
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
26
Marshall Wace North America
New York
$1.39M +$818K +100,878 New
MIM
27
Monashee Investment Management
Massachusetts
$1.38M – – –
SG Americas Securities
28
SG Americas Securities
New York
$1.3M +$765K +94,269 New
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$1.24M +$223K +27,482 +44%
EGI
30
EAM Global Investors
California
$1.2M +$703K +86,614 New
Alkeon Capital Management
31
Alkeon Capital Management
New York
$1.17M +$690K +85,000 New
Ameriprise
32
Ameriprise
Minnesota
$1.14M +$672K +82,882 New
PPA
33
Parametric Portfolio Associates
Washington
$1.07M +$629K +77,518 New
MCM
34
Moore Capital Management
New York
$1.03M +$608K +75,000 New
OAM
35
Oxford Asset Management
United Kingdom
$1.03M +$404K +49,791 +194%
VF
36
Virtu Financial
New York
$1.01M +$486K +59,955 +459%
MS
37
Maven Securities
Jersey
$989K +$588K +72,464 New
ECM
38
Endurant Capital Management
California
$966K +$568K +70,000 New
WC
39
Woodstock Corp
Massachusetts
$935K – – –
Simplex Trading
40
Simplex Trading
Illinois
$810K +$452K +55,767 +1,873%
AAP
41
Ardsley Advisory Partners
Connecticut
$759K +$81.1K +10,000 +22%
CI
42
Cowen Inc
New York
$600K +$353K +43,500 New
Two Sigma Investments
43
Two Sigma Investments
New York
$565K +$332K +40,929 New
DS
44
DRW Securities
Illinois
$561K +$192K +23,681 +139%
TI
45
Trexquant Investment
Connecticut
$535K +$314K +38,736 New
Deutsche Bank
46
Deutsche Bank
Germany
$530K +$63.5K +7,823 +26%
MFIM
47
Mesirow Financial Investment Management
Illinois
$526K -$24.6K -3,031 -7%
Morgan Stanley
48
Morgan Stanley
New York
$500K -$53.1K -6,546 -15%
FIA
49
FNY Investment Advisers
New York
$419K +$166K +20,405 +204%
Charles Schwab
50
Charles Schwab
California
$410K – – –
1
2
3 4

ALDX Hedge Fund Activity: Q3 2018 in Review

89 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q3 2018, worth a combined $249M — up 158% from $96.4M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ALDX positions and 8 closed out — a net gain of 23 holders — while 31 added to existing stakes and 13 trimmed.

The largest buyer was Citigroup, adding an estimated $8.27M. The largest seller was Adage Capital Partners, cutting an estimated $2.91M.

  • 89 institutional investors held Aldeyra Therapeutics (ALDX) as of Q3 2018, up from 66 in Q2 2018.
  • Funds reported $249M of Aldeyra Therapeutics stock for Q3 2018, up 158% quarter-over-quarter.
  • 31 funds opened new Aldeyra Therapeutics positions in Q3 2018 and 8 closed out, a net change of +23 holders.
  • The largest Aldeyra Therapeutics buyer in Q3 2018 was Citigroup, an estimated $8.27M added.
  • The largest Aldeyra Therapeutics seller in Q3 2018 was Adage Capital Partners, an estimated $2.91M sold.

Based on aggregated 13F filings for Q3 2018.